Peptide glossary · Reading the research
Phase 1, 2 and 3 trials
Checked against NCI Dictionary of Cancer Terms (National Cancer Institute)Published by PepVault
New drugs are tested in people in phases: phase 1 for safety and dose, phase 2 for whether it works, phase 3 against standard treatment.
What it means
A drug usually moves to the next phase only after meeting the goals of the one before. Retatrutide has phase 3 results and isn’t approved yet; KPV, like many research peptides, hasn’t been tested in people at all.
Why it matters when you track peptides
A compound’s phase tells you how much is known about it in people, the context for any change you log.

Where you meet it
Checked against
NCI Dictionary of Cancer Terms (National Cancer Institute), “phase III clinical trial”